期刊文献+

贝力斯治疗脑脊髓病变后肢体痉挛性瘫痪的疗效观察 被引量:1

Therapeutic effect of Beilishi to the limb spastic paralysis with encephalomyelopathy
下载PDF
导出
摘要 目的 观察贝力斯治疗脑脊髓病变后肢体痉挛性瘫痪的临床疗效。方法  12 0例脑脊髓病变后肢体痉挛性瘫痪的患者服用贝力斯 4周。结果 贝力斯治疗痉挛性瘫痪的总有效率为 79.2 % ,治疗前后肌张力的变化、患者主观症状 (失眠除外 )的改善具统计学意义 (P <0 .0 5 )。结论 贝力斯能够有效地治疗脑脊髓病变后肢体痉挛性瘫痪的患者。 OBJECTIVE To observe the influence of Beilishi to the limb spastic paralysis with encephalomyelopath.METHODS 120 patients took Beilishi for 4 weeks.RESULTS The total effective rate was 79.2%.The change in muscle tension and subjective symptom,except insomnia,had the statistical significant different.CONCLUSION Beilishi have the therapeutic effect to the limb spastic paralysis with encephalomyelopath.
出处 《华西药学杂志》 CAS CSCD 2004年第4期312-313,共2页 West China Journal of Pharmaceutical Sciences
关键词 贝力斯 脑脊髓 肢体痉挛性瘫痪 脑卒中 给药方法 Encephalomyelopath Spastic paralysis Beilishi
  • 相关文献

参考文献2

二级参考文献112

  • 1Smitb C, Birmbaum G, Carter JL, Greenstein J, Lublin FD, US Tizamdine Scudy Group, Tizanidine trcaunent of spasticity caused by multiple sclerosis, Neurology 1994;44(Suppl 9);S34-43.
  • 2The United Kijlgdom Tizanldine Trlal Group. A doublc-bbnd. Placebo-conetrolled trial of tizanichne in the treatment of spasticity caused by muluple sclerosis. Neurology 1994:44(Suppl 9):S70-8.
  • 3Wallace JD. Surnmry of combiued clinacal analysis of coturollel clinical trials with tizaridine. Neurology,1994;44(Suppl 9):560-9.
  • 4Mathias CJ.Luckier J. Desai P, Baker H.Maso WE Frankel HL.Pharmacodynamics and pharmacokinetics of the and anospastic agent tizamdine in patients with spinal cord injury J Rehabl Res Dev 1989;26:9-16.
  • 5Nance J. Bugaresn J. Shellenberger K, Sheremata W, Martinez-Anizala A. North American Tizanidme Study Group. EfFicacy., and safety of tizanidine in the treatment of spasticity, in pauents with spina1 cord injury, Neurology 1994;14(Suppl 9):S44-52.
  • 6Medici M. Pebet M, Ciblis D A double-bhnd,long-term study. of tizanidine (Sirdalud)in spasticlty due to cerebrmvascular lestons .Curr Med Res Opin 1989;11:398-407.
  • 7Bes A.Eyssette M.Pterrot-Deseillgny E.et al.A.multi-centre.double-blind trial of tizanidine a new antispasticity agent in spasticity associated with hemiplegia Curr Mcd Res Opin 1988:10:7199-18.
  • 8Pedersen E.Clinical.assessment and pharmacologic therapy of spastcity Arch Phys Med R ehahal 1974;55:344-54.
  • 9Nance PW.Shears AH. Nance DM Rcflex changes induced hy clomdine in spinal cord injured patient, Paraplegia 1989:27:296-301.
  • 10Donovan WH, Carter RE, Rossi CD. Wilkerson MA Clonidine effect on spasticily: A clinical real Arch Phys Med Rchabil 1988;69:193-4.

共引文献8

同被引文献14

  • 1宋建良,孙新芳,金国良,丁靖.妙纳治疗紧张性头痛的临床观察[J].实用中西医结合临床,2005,5(4):42-43. 被引量:2
  • 2赵跃,谢瑛,郝永玲.盐酸替扎尼定引起精神症状[J].药物不良反应杂志,2007,9(3):207-207. 被引量:5
  • 3程佩素.巴氯芬的临床应用进展[J].西北药学杂志,2007,22(4):217-218. 被引量:3
  • 4Taricco M, Pagliacci MC, Telaro E, et al. Pharmacological interventionsfor spasticity following spinal cord injury: results of a Cochrane system-atic review [J]. Eura Medicophys, 2006, 42(1): 5-15.
  • 5Nance PW, Bugaresti J, Shellenberger K, et al. Efficacy and safety of ti-zanidine in the treatment of spasticity in patients with spinal cord inju-ry [J]. Neurology, 1994, 44(Suppl 9): 44-52.
  • 6Wagstaff AJ, Bryson HM. Tizanidine. A review of its pharmacology,clinical efficacy and tolerability in the management of spasticity associ-ated with cerebral and spinal disorders [J], Drugs, 1997, 53(3): 435-452.
  • 7Kamen L, Henney HR 3rd, Runyan JD. A practical overview of tizani-dine use for spasticity secondary to multiple sclerosis, stroke, and spi-nal cord injury [J]. Curr Med Res Opin, 2008,24(2): 425-439.
  • 8于生元.妙纳治疗颈源性头痛有效性和安全性的临床观察[J].中国疼痛医学杂志,2005,11(8): 29.
  • 9Rabchevsky AG, Kitzman PH. Latest approaches for the treatment ofspasticity and autonomic dysreflexia in chronic spinal cord injury [J].Neurotherapeutics, 2011,8(2): 274-282.
  • 10刘根林,李建军,周红俊,郑樱,郝春霞,汪家琮.Baclofen治疗脊髓损伤后痉挛的疗效观察[J].中国康复理论与实践,2008,14(1):77-78. 被引量:3

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部